Suppr超能文献

大直径(5.5-6 毫米)Derivo 栓塞装置在颅内动脉瘤治疗中的植入。

Implantation of Large Diameter (5.5-6 mm) Derivo Embolization Devices for the Treatment of Cerebral Aneurysms.

机构信息

Interventional Neuroradiology, Hull Royal Infirmary, Hull University Teaching Hospitals NHS Trust, Hull, UK.

Interventional Neuroradiology, Queens Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK.

出版信息

Clin Neuroradiol. 2022 Jun;32(2):481-489. doi: 10.1007/s00062-021-01086-2. Epub 2021 Sep 8.

Abstract

BACKGROUND

The efficacy of flow diverters is dependent upon robust wall apposition in the parent artery. Usage in large caliber cerebral vessels has therefore been limited as few implants with diameters > 5 mm exist. We present our initial experience in treating cerebral aneurysms using the 5.5 mm and 6 mm diameter implants of the Derivo embolization device (DED).

METHODS

Our prospectively maintained institutional database was reviewed to identify patients in whom a > 5 mm DED was implanted between November 2016 and February 2021. The primary efficacy outcome was complete or near-complete aneurysm occlusion at 6 months (O'Kelly-Marotta, OKM, C-D, adapted for magnetic resonance angiography). Safety outcomes included 30-day major morbidity defined as modified Rankin Score (mRS) 3-5, mortality, serious adverse events and procedural complications.

RESULTS

A total of 21 large diameter DEDs were deployed in 18 patients (age 59.5 ± 14.1 years), harboring 19 unruptured aneurysms. Of the aneurysms 14 (73.7%) were saccular in morphology (sac diameter 10.9 ± 5.5 mm, neck diameter 6.8 ± 3.1 mm), 3 (15.8%) aneurysms were dissecting, 1 (5.3%) iatrogenic pseudoaneurysm and 1 (5.3%) fusiform. Aneurysm locations were: ICA (internal carotid artery) (n = 17); (7 cavernous, 4 paraophthalmic, 2 paraclinoid, 1 petrous, 2 communicating, 1 cervical); vertebrobasilar (n = 2). Adjunct stenting to optimize proximal wall apposition was undertaken in 5 (27.8%) patients. At 6 months 75% of patients followed-up met the primary efficacy endpoint (OKM C-D). There were no serious adverse events, 30-day major morbidity (mRS 3-5) or mortality.

CONCLUSION

Implantation of large diameter (5.5 mm and 6 mm) DEDs into capacious cerebral vessels to treat a range of complex aneurysms is safe and technically feasible but may require adjunct stenting to optimize proximal wall apposition. Short-term efficacy of this device subset is comparable to previous DED and other flow diverter studies. Long-term follow-up and comparative studies are required for further assessment.

摘要

背景

血流导向装置的疗效取决于在母动脉中牢固的贴壁。由于存在的直径 > 5mm 的植入物很少,因此在大口径脑血管中的使用受到限制。我们介绍了使用 Derivo 栓塞装置(DED)的 5.5mm 和 6mm 直径植入物治疗脑动脉瘤的初步经验。

方法

我们对 2016 年 11 月至 2021 年 2 月期间使用 > 5mmDED 治疗的患者进行了前瞻性维护的机构数据库回顾。主要疗效终点是 6 个月时完全或接近完全闭塞(O'Kelly-Marotta,OKM,C-D,适用于磁共振血管造影)。安全性结果包括 30 天主要发病率(改良 Rankin 评分 [mRS] 3-5)、死亡率、严重不良事件和程序并发症。

结果

共在 18 名患者(年龄 59.5 ± 14.1 岁)中植入了 21 个大直径 DED,其中 19 个未破裂的动脉瘤。在这些动脉瘤中,14 个(73.7%)为囊状(囊直径 10.9 ± 5.5mm,颈直径 6.8 ± 3.1mm),3 个(15.8%)为夹层动脉瘤,1 个(5.3%)为医源性假性动脉瘤,1 个(5.3%)为梭形。动脉瘤位置为:ICA(颈内动脉)(n=17);(7 个海绵窦,4 个眶周,2 个眶后,1 个岩骨,2 个交通,1 个颈);椎基底动脉(n=2)。为了优化近端贴壁,5 名患者(27.8%)接受了辅助支架置入术。在随访的 6 个月时,75%的患者达到了主要疗效终点(OKM C-D)。无严重不良事件、30 天主要发病率(mRS 3-5)或死亡率。

结论

将大直径(5.5mm 和 6mm)DED 植入到大容量脑血管中治疗一系列复杂的动脉瘤是安全且技术上可行的,但可能需要辅助支架置入术来优化近端贴壁。这种装置亚组的短期疗效与之前的 DED 和其他血流导向装置研究相当。需要进一步评估长期随访和比较研究。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验